Correlation Between NYSE Composite and Maravai Lifesciences
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Maravai Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Maravai Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Maravai Lifesciences Holdings, you can compare the effects of market volatilities on NYSE Composite and Maravai Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Maravai Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Maravai Lifesciences.
Diversification Opportunities for NYSE Composite and Maravai Lifesciences
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NYSE and Maravai is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Maravai Lifesciences Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maravai Lifesciences and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Maravai Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maravai Lifesciences has no effect on the direction of NYSE Composite i.e., NYSE Composite and Maravai Lifesciences go up and down completely randomly.
Pair Corralation between NYSE Composite and Maravai Lifesciences
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.14 times more return on investment than Maravai Lifesciences. However, NYSE Composite is 7.36 times less risky than Maravai Lifesciences. It trades about 0.08 of its potential returns per unit of risk. Maravai Lifesciences Holdings is currently generating about -0.02 per unit of risk. If you would invest 1,589,536 in NYSE Composite on August 27, 2024 and sell it today you would earn a total of 422,809 from holding NYSE Composite or generate 26.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Maravai Lifesciences Holdings
Performance |
| Timeline |
NYSE Composite and Maravai Lifesciences Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Maravai Lifesciences Holdings
Pair trading matchups for Maravai Lifesciences
Pair Trading with NYSE Composite and Maravai Lifesciences
The main advantage of trading using opposite NYSE Composite and Maravai Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Maravai Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maravai Lifesciences will offset losses from the drop in Maravai Lifesciences' long position.| NYSE Composite vs. Hooker Furniture | NYSE Composite vs. Hudson Pacific Properties | NYSE Composite vs. Canlan Ice Sports | NYSE Composite vs. Boston Properties |
| Maravai Lifesciences vs. Roivant Sciences | Maravai Lifesciences vs. Krystal Biotech | Maravai Lifesciences vs. Akero Therapeutics | Maravai Lifesciences vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |